Galvanize Therapeutics Completes First Commercial Procedures With Aliya® EX System

Galvanize Therapeutics announced it has completed the first commercial procedures utilizing its new Aliya® EX system. The company states this next-generation Pulsed Electric Field (PEF) system enhances interventional capabilities for both percutaneous and endoscopic approaches.

REDWOOD CITY, Calif. – The Aliya® EX system is designed to advance cancer treatment options. Galvanize Therapeutics is a commercial-stage medical technology company focused on developing PEF-based therapies.

Percutaneous procedures are performed through the skin, while endoscopic procedures involve the use of an endoscope. The expanded applicability of the Aliya® EX system is expected to improve patient treatment options and enable new therapeutic approaches for various cancer types.

The commercial use of the Aliya® EX system represents a notable advancement for Galvanize Therapeutics' strategy to offer novel treatment modalities. The company has not yet released specific outcomes from these initial procedures.